SuperworthAlaunos Therapeutics market cap TCRT
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $5.8M
- Highest close in our data
- $1.8B
- Nov 2015
Alaunos Therapeutics is worth $5.8M at the close on Oct 23, 2026, at $2.28 a share.
That is down 6% over the last year and down 98% over five years.
Its highest close in our data was $1.8B in Nov 2015.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $5.8M | $2M | $69.6M | −20% |
| 2025 | $7.2M | $2.3M | $9.5M | +145% |
| 2024 | $2.9M | $2.9M | $42.3M | −83% |
| 2023 | $17M | $11M | $172.4M | −88% |
| 2022 | $140.3M | $103.5M | $797.7M | −40% |
| 2021 | $235.6M | $235.6M | $1.1B | −56% |
| 2020 | $540M | $447.6M | $845.4M | −42% |
| 2019 | $932.3M | $301.8M | $1.1B | +294% |
| 2018 | $236.4M | $236.4M | $696.3M | −60% |
| 2017 | $587.7M | $574.9M | $974.3M | −17% |
| 2016 | $704.8M | $592M | $1.2B | −35% |
| 2015 | $1.1B | $526.9M | $1.8B | +116% |
| 2014 | $503.3M | $244.8M | $519.9M | +39% |
| 2013 | $361.6M | $128.1M | $446.7M | +8% |
| 2012 | $335.2M | $284.1M | $494.6M | +11% |
| 2011 | $301.9M | $228.2M | $358.4M | n/a |
Against its peers
Companies in Healthcare nearest Alaunos Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| TCRTAlaunos Therapeutics | $5.8M |
| NEPHNephros | $38.3M |
| ATNMActinium Pharmaceuticals | $47.8M |
| APTAlpha Pro Tech | $56.7M |
| Peer median | $47.8M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Alaunos Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.